Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294507395> ?p ?o ?g. }
- W4294507395 abstract "Abstract Background Standard amino acid solutions have recently been removed from the contraindications for use in dialysis patients in Japan. However, the details of their safety and efficacy in these patients are still not known. In this study, we investigated the safety and efficacy of intradialytic parenteral nutrition (IDPN) using ENEFLUID® injection containing standard amino acids, glucose, electrolytes, fats, and water-soluble vitamins in maintenance hemodialysis patients with malnutrition. Methods This clinical trial was designed as a multicenter, prospective, non-randomized, open-label, single-arm, observational pilot study. The participants were patients on maintenance hemodialysis who were in the nutritional high-risk group according to the Nutritional Risk Index for Japanese Hemodialysis Patients. One bag of ENEFLUID® injection was administered during every hemodialysis session for 12 weeks. The primary endpoint was change in serum transthyretin levels between before and after the 12-week period. As safety endpoints, we evaluated changes in body fluid volume and blood biochemical tests, including blood urea nitrogen and electrolytes, as well as blood glucose variability using flash glucose monitoring (FGM). Results The mean age and body mass index of the 13 participants were 79.0 ± 10.7 years and 18.0 ± 1.7 kg/m 2 , respectively. No significant changes were observed in nutritional parameters, including serum transthyretin, between before and after the start of the study. After IDPN initiation, there was no obvious fluid overload or significant changes in blood biochemical tests, including electrolytes, and the treatment could be safely continued for 12 weeks. In the FGM analysis, asymptomatic hypoglycemia during hemodialysis was observed at the beginning of the study, but there was a trend toward improvement after 12 weeks (area over the curve < 70 mg/dl per dialysis session: 747.5 ± 1333.9 to 21.6 ± 54.3, P = 0.09). Conclusions IDPN using ENEFLUID® injection can be safely continued, although it does not significantly improve markers of nutritional status. It also showed the potential to ameliorate asymptomatic hypoglycemia during hemodialysis sessions. More detailed studies of the improvement in nutritional indicators are needed. Trial registration : This study was registered with the University Hospital Medical Information Network-Clinical Trials Registry (UMIN-CTR) on May 9, 2021 (registration ID, UMIN000044051)." @default.
- W4294507395 created "2022-09-03" @default.
- W4294507395 creator A5002881989 @default.
- W4294507395 creator A5004119000 @default.
- W4294507395 creator A5034883318 @default.
- W4294507395 creator A5035148899 @default.
- W4294507395 creator A5042533774 @default.
- W4294507395 creator A5047244826 @default.
- W4294507395 creator A5064072910 @default.
- W4294507395 creator A5074733950 @default.
- W4294507395 date "2022-09-03" @default.
- W4294507395 modified "2023-09-25" @default.
- W4294507395 title "Intradialytic parenteral nutrition using a standard amino acid solution not for renal failure in maintenance hemodialysis patients with malnutrition: a multicenter pilot study" @default.
- W4294507395 cites W1806089932 @default.
- W4294507395 cites W1913470798 @default.
- W4294507395 cites W1966232124 @default.
- W4294507395 cites W1967265218 @default.
- W4294507395 cites W1989135512 @default.
- W4294507395 cites W2018395490 @default.
- W4294507395 cites W2019124972 @default.
- W4294507395 cites W2026965239 @default.
- W4294507395 cites W2050680161 @default.
- W4294507395 cites W2083797416 @default.
- W4294507395 cites W2104976959 @default.
- W4294507395 cites W2112509941 @default.
- W4294507395 cites W2117689581 @default.
- W4294507395 cites W2121960517 @default.
- W4294507395 cites W2126097654 @default.
- W4294507395 cites W2131437421 @default.
- W4294507395 cites W2131967146 @default.
- W4294507395 cites W2138435691 @default.
- W4294507395 cites W2146702281 @default.
- W4294507395 cites W2154430576 @default.
- W4294507395 cites W2161458598 @default.
- W4294507395 cites W2197254910 @default.
- W4294507395 cites W2227033802 @default.
- W4294507395 cites W2469651267 @default.
- W4294507395 cites W2774870903 @default.
- W4294507395 cites W2789321579 @default.
- W4294507395 cites W2793088148 @default.
- W4294507395 cites W2913553909 @default.
- W4294507395 cites W2918092070 @default.
- W4294507395 cites W2921274029 @default.
- W4294507395 cites W2924763979 @default.
- W4294507395 cites W2981142390 @default.
- W4294507395 cites W2995590823 @default.
- W4294507395 cites W3074864365 @default.
- W4294507395 cites W3126596162 @default.
- W4294507395 cites W4226300761 @default.
- W4294507395 cites W597962540 @default.
- W4294507395 doi "https://doi.org/10.1186/s41100-022-00432-5" @default.
- W4294507395 hasPublicationYear "2022" @default.
- W4294507395 type Work @default.
- W4294507395 citedByCount "1" @default.
- W4294507395 countsByYear W42945073952023 @default.
- W4294507395 crossrefType "journal-article" @default.
- W4294507395 hasAuthorship W4294507395A5002881989 @default.
- W4294507395 hasAuthorship W4294507395A5004119000 @default.
- W4294507395 hasAuthorship W4294507395A5034883318 @default.
- W4294507395 hasAuthorship W4294507395A5035148899 @default.
- W4294507395 hasAuthorship W4294507395A5042533774 @default.
- W4294507395 hasAuthorship W4294507395A5047244826 @default.
- W4294507395 hasAuthorship W4294507395A5064072910 @default.
- W4294507395 hasAuthorship W4294507395A5074733950 @default.
- W4294507395 hasBestOaLocation W42945073951 @default.
- W4294507395 hasConcept C126322002 @default.
- W4294507395 hasConcept C141071460 @default.
- W4294507395 hasConcept C168563851 @default.
- W4294507395 hasConcept C203092338 @default.
- W4294507395 hasConcept C2777910003 @default.
- W4294507395 hasConcept C2778063415 @default.
- W4294507395 hasConcept C2778176769 @default.
- W4294507395 hasConcept C2779541074 @default.
- W4294507395 hasConcept C2779978075 @default.
- W4294507395 hasConcept C2780306776 @default.
- W4294507395 hasConcept C551997983 @default.
- W4294507395 hasConcept C71924100 @default.
- W4294507395 hasConcept C78722104 @default.
- W4294507395 hasConceptScore W4294507395C126322002 @default.
- W4294507395 hasConceptScore W4294507395C141071460 @default.
- W4294507395 hasConceptScore W4294507395C168563851 @default.
- W4294507395 hasConceptScore W4294507395C203092338 @default.
- W4294507395 hasConceptScore W4294507395C2777910003 @default.
- W4294507395 hasConceptScore W4294507395C2778063415 @default.
- W4294507395 hasConceptScore W4294507395C2778176769 @default.
- W4294507395 hasConceptScore W4294507395C2779541074 @default.
- W4294507395 hasConceptScore W4294507395C2779978075 @default.
- W4294507395 hasConceptScore W4294507395C2780306776 @default.
- W4294507395 hasConceptScore W4294507395C551997983 @default.
- W4294507395 hasConceptScore W4294507395C71924100 @default.
- W4294507395 hasConceptScore W4294507395C78722104 @default.
- W4294507395 hasIssue "1" @default.
- W4294507395 hasLocation W42945073951 @default.
- W4294507395 hasLocation W42945073952 @default.
- W4294507395 hasOpenAccess W4294507395 @default.
- W4294507395 hasPrimaryLocation W42945073951 @default.
- W4294507395 hasRelatedWork W113810927 @default.
- W4294507395 hasRelatedWork W1978605914 @default.
- W4294507395 hasRelatedWork W2010978499 @default.
- W4294507395 hasRelatedWork W2124423525 @default.